D

Anika Therapeutics, Inc. ANIK

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$12.76$13.84
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 9.98% 15.56% 13.16% 0.04% -28.22%
Total Other Revenue -- -- -- -- --
Total Revenue 9.98% 15.56% 13.16% 0.04% -28.22%
Cost of Revenue -3.89% -17.97% -7.59% -11.14% -67.22%
Gross Profit 20.87% 47.91% 29.40% 8.16% 982.22%
SG&A Expenses -2.90% -16.79% 25.41% 6.68% -37.89%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 0.42% -10.85% 10.05% -2.38% -51.23%
Operating Income 81.91% 189.14% 8.94% 752.53% 87.02%
Income Before Tax 85.60% 185.22% -24.61% 1,858.97% 91.90%
Income Tax Expenses -101.17% -89.57% 164.04% -141.07% -59.30%
Earnings from Continuing Operations 90.20% 171.21% -27.74% 172.45% 89.39%
Earnings from Discontinued Operations -- -- -- 92.21% --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 86.65% 183.35% -3.76% 101.34% 92.22%
EBIT 81.91% 189.14% 8.94% 752.53% 87.02%
EBITDA 146.67% 279.57% 7.36% 47.12% 91.95%
EPS Basic 85.63% 189.80% -9.65% 101.37% 92.03%
Normalized Basic EPS 90.61% 212.80% 11.65% 20.94% 90.66%
EPS Diluted 85.63% 184.69% -8.63% 101.05% 92.04%
Normalized Diluted EPS 90.61% 210.84% 11.65% 18.12% 90.66%
Average Basic Shares Outstanding -7.15% -7.20% -5.36% -2.08% -2.36%
Average Diluted Shares Outstanding -7.15% -5.51% -5.36% 0.31% -2.36%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --